Caleres Inc (CAL)
NYSE:CAL
Want to see CAL full AI Analyst Report?
Top Page
Caleres
(NYSE:CAL)
Select Model
Select Model
Rating:63Neutral
Price Target:
$15.00
▲(9.41% Upside)
Action:Reiterated
Date:06/04/26
The score is driven by improving near-term outlook and solid technical momentum, supported by balance-sheet de-risking and steady cash generation. Offsetting these positives are the recent drop in profitability (including a net loss), a negative P/E, and execution/macro risks tied to Famous Footwear weakness and tariff uncertainty.
Positive Factors
Improved leverage and stronger balance sheet
Caleres has materially de-levered from very elevated leverage to debt-to-equity under 1x, with equity expansion since 2021. This stronger capital structure reduces interest and refinancing risk, increases financial flexibility for stores, capex, or M&A, and supports resilience through cyclical demand over the next several quarters.
Negative Factors
Recent swing to a net loss and compressed operating margins
The company's move from multi-year profits to a small net loss highlights earnings fragility and volatility. Compressed operating margins reduce internal reinvestment capacity, lower returns on equity, and mean longer reliance on operational fixes to restore sustainable profitability across business cycles.
Read all positive and negative factors
Positive Factors
Negative Factors
Improved leverage and stronger balance sheet
Caleres has materially de-levered from very elevated leverage to debt-to-equity under 1x, with equity expansion since 2021. This stronger capital structure reduces interest and refinancing risk, increases financial flexibility for stores, capex, or M&A, and supports resilience through cyclical demand over the next several quarters.
Read all positive factors
Caleres Key Performance Indicators (KPIs)
Any
Gross Profit By Segment
Highlights the profitability of each business segment, showing which areas are driving earnings and where there may be challenges in cost management or pricing power.
Highlights the profitability of each business segment, showing which areas are driving earnings and where there may be challenges in cost management or pricing power.
Data provided by:
The Fly
The FlyCaleres (CAL) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$479.46M
Dividend Yield2.11%
Average Volume (3M)619.53K
Price to Earnings (P/E)1436.5
Beta (1Y)1.41
Revenue Growth4.95%
EPS Growth-100.25%
CountryUS
Employees4,800
SectorConsumer Cyclical
Sector Strength84
IndustryApparel - Footwear & Accessories
Share Statistics
EPS (TTM)-0.22
Shares Outstanding33,740,818
10 Day Avg. Volume677,327
30 Day Avg. Volume619,527
Financial Highlights & Ratios
PEG Ratio0.53
Price to Book (P/B)0.66
Price to Sales (P/S)0.14
P/FCF Ratio12.28
Enterprise Value/Market Cap2.82
Enterprise Value/Revenue0.49
Enterprise Value/Gross Profit1.14
Enterprise Value/Ebitda30.27
Forecast
1Y Price Target
$16.00Price Target Upside16.70% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)1.58
Revenue Forecast (FY)$2.88B
Caleres Business Overview & Revenue Model
Company Description
Caleres, Inc. engages in the retail and wholesale of footwear in the United States, Canada, China, and Guam. It operates through Famous Footwear and Brand Portfolio segments. The company offers licensed, branded, and private-label athletic, casual...
How the Company Makes Money
Caleres makes money primarily by selling footwear (and, to a lesser extent, footwear-related accessories) through two main channels: (1) wholesale and (2) direct-to-consumer (DTC). In wholesale, Caleres sells branded products to third-party retail...
Caleres Earnings Call Summary
Earnings Call Date:Jun 04, 2026
(Q1-2026)
| % Change Since: |
Next Earnings Date:Sep 02, 2026
Earnings Call Sentiment Positive
The call highlighted strong performance and margin expansion within the Brand Portfolio — driven by lead brands, e-commerce, international growth and successful Stuart Weitzman integration — resulting in consolidated sales growth and an EPS beat. However, Famous Footwear showed softness with declining comps, compressing margins, and management flagged tariff uncertainty, acquisition-related SG&A pressure and inventory considerations. The positives in Brand Portfolio and operational momentum materially outweigh the Famous-specific challenges and one-time acquisition impacts.Positive Updates
Consolidated Sales Growth and EPS Beat
First quarter sales of $667.0M, up 8.5% year-over-year; reported diluted EPS of $0.38 vs $0.22 a year ago and above guidance.
Negative Updates
Famous Footwear Sales and Traffic Weakness
Famous total sales down 2.5% with comparable sales down 2.3%; comp sales were positive in February but declined mid-single digits in the March-April period and guidance anticipates continued mid-single-digit declines in Q2.
Read all updates
Q1-2026 Updates
Positive
Negative
Consolidated Sales Growth and EPS Beat
First quarter sales of $667.0M, up 8.5% year-over-year; reported diluted EPS of $0.38 vs $0.22 a year ago and above guidance.
Read all positive updates
Company Guidance
The company guided Q2 consolidated sales up mid- to high-single digits with Brand Portfolio sales up in the mid-20% range (inclusive of low double-digit organic growth) and Famous Footwear sales and comps down mid-single digits; it expects to open 3 stores and close 2 in Q2, consolidated gross margin to expand 345–375 bps, SG&A to deleverage 325–375 bps, a tax rate of 26–27% and GAAP EPS of $0.32–$0.38. For fiscal 2026 the outlook is consolidated sales up low- to mid-single digits, Brand Portfolio sales up low double digits (mid-single digits organically), Famous down low- to mid-single digits, 12 store openings and 15 closures, consolidated gross margin up 220–260 bps, SG&A rate flat to slightly deleveraged, interest expense of ~$18 million, a tax rate of 27–28%, GAAP EPS $1.44–$1.69 (adjusted EPS $1.40–$1.65) and CapEx of ~$50–55 million. Guidance assumes new tariffs will be enacted in July 2026 to largely replace prior IEEPA tariffs; the company estimates it is eligible for approximately $57.8 million plus interest in IEEPA refunds but has not recorded a receivable or included any refund in guidance given legal/regulatory uncertainty and macro risks (elevated inflation/possible slowdown).Caleres Financial Statement Overview
Summary
Income Statement
42
Neutral
Balance Sheet
58
Neutral
Cash Flow
64
Positive
| Breakdown | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.76B | 2.72B | 2.82B | 2.97B | 2.78B |
| Gross Profit | 1.18B | 1.22B | 1.26B | 1.28B | 1.23B |
| EBITDA | 70.82M | 205.54M | 253.94M | 276.31M | 257.08M |
| Net Income | -7.05M | 107.25M | 163.87M | 181.74M | 137.02M |
Balance Sheet | |||||
| Total Assets | 1.97B | 1.89B | 1.80B | 1.84B | 1.84B |
| Cash, Cash Equivalents and Short-Term Investments | 29.77M | 29.64M | 21.36M | 33.70M | 30.11M |
| Total Debt | 891.13M | 826.55M | 747.86M | 887.63M | 871.40M |
| Total Liabilities | 1.36B | 1.29B | 1.24B | 1.41B | 1.52B |
| Stockholders Equity | 601.85M | 599.02M | 560.63M | 420.68M | 318.57M |
Cash Flow | |||||
| Free Cash Flow | 32.37M | 55.41M | 150.53M | 61.84M | 144.30M |
| Operating Cash Flow | 100.26M | 104.56M | 200.15M | 125.88M | 168.44M |
| Investing Cash Flow | -158.83M | -51.69M | -49.62M | -64.04M | -24.14M |
| Financing Cash Flow | 58.65M | -44.51M | -162.99M | -58.15M | -202.38M |
Caleres Technical Analysis
Negative
13.71
Price Trends
12.68
Negative
12.23
Positive
12.58
Negative
Market Momentum
0.37
Negative
43.32
Neutral
46.16
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CAL, the sentiment is Negative. The current price of 13.71 is above the 20-day moving average (MA) of 12.90, above the 50-day MA of 12.68, and above the 200-day MA of 12.58, indicating a bearish trend. The MACD of 0.37 indicates Negative momentum. The RSI at 43.32 is Neutral, neither overbought nor oversold. The STOCH value of 46.16 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CAL.
Caleres Risk Analysis
Caleres disclosed 32 risk factors in its most recent earnings report. Caleres reported the most risks in the "Ability to Sell" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Caleres Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $338.30M | 13.96 | 9.63% | 9.66% | -3.70% | -18.57% | |
66 Neutral | $3.25B | 41.20 | 8.78% | 1.97% | 15.48% | -54.34% | |
64 Neutral | $281.14M | 15.18 | 7.51% | 2.08% | 8.21% | 34.42% | |
64 Neutral | $1.31B | 12.50 | 26.91% | 2.28% | 8.31% | 39.91% | |
63 Neutral | $479.46M | 1,436.50 | -1.16% | 2.11% | 4.95% | -100.25% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | $6.04B | -57.85 | -7.54% | ― | -1.85% | -108.05% |
* Consumer Cyclical Sector Average
CAL
Caleres
12.37
-0.98
-7.35%
CROX
Crocs
119.35
17.89
17.63%
RCKY
Rocky Brands
37.45
14.58
63.73%
SHOO
Steven Madden
44.03
19.71
81.05%
WEYS
Weyco Group
35.08
5.77
19.68%
WWW
Wolverine World Wide
15.90
-1.48
-8.53%
Caleres Corporate Events
Business Operations and StrategyExecutive/Board ChangesShareholder Meetings
Caleres Streamlines Board Structure After Shareholder Approvals
Positive
May 28, 2026
On May 28, 2026, Caleres’ board amended its bylaws to reduce the size of the board from eleven to ten directors, effective the same date, aligning governance structure with the ten directors elected at the company’s 2026 annual meeting...
Business Operations and StrategyExecutive/Board ChangesFinancial Disclosures
Caleres Names Permanent CFO, Signals Stronger Outlook
Positive
May 20, 2026
Caleres announced on May 20, 2026, that longtime finance executive Dan Karpel has been appointed senior vice president and chief financial officer, effective immediately, after serving as interim CFO since January 2026 and previously holding senio...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.